Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4634930
Max Phase: Preclinical
Molecular Formula: C29H21NO10
Molecular Weight: 543.48
Molecule Type: Unknown
Associated Items:
ID: ALA4634930
Max Phase: Preclinical
Molecular Formula: C29H21NO10
Molecular Weight: 543.48
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@H](O)[C@@](C)(O)[C@@]12O[C@]13c1cc(O)c4c(c1N[C@H]2C#C/C=C\C#C[C@H]3O)C(=O)c1cc(O)ccc1C4=O
Standard InChI: InChI=1S/C29H21NO10/c1-27(38,25(36)26(37)39-2)29-18-7-5-3-4-6-8-19(33)28(29,40-29)16-12-17(32)20-21(22(16)30-18)24(35)15-11-13(31)9-10-14(15)23(20)34/h3-4,9-12,18-19,25,30-33,36,38H,1-2H3/b4-3-/t18-,19+,25-,27+,28-,29+/m0/s1
Standard InChI Key: SRBWZZOBDMCFHB-XIQYBZFWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 543.48 | Molecular Weight (Monoisotopic): 543.1165 | AlogP: -0.15 | #Rotatable Bonds: 3 |
Polar Surface Area: 186.15 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 7.24 | CX Basic pKa: | CX LogP: 2.11 | CX LogD: 1.72 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.11 | Np Likeness Score: 1.85 |
1. Adhikari A, Teijaro CN, Yan X, Chang CY, Gui C, Liu YC, Crnovcic I, Yang D, Annaval T, Rader C, Shen B.. (2020) Characterization of TnmH as an O-Methyltransferase Revealing Insights into Tiancimycin Biosynthesis and Enabling a Biocatalytic Strategy To Prepare Antibody-Tiancimycin Conjugates., 63 (15): [PMID:32658465] [10.1021/acs.jmedchem.0c00799] |
Source(1):